TIMES OF ISRAEL
Israeli COVID vaccine in pill form to start clinical trial in Tel Aviv
by Nathan Jeffay
July 22, 2021

A prospective oral coronavirus vaccine is set to start clinical trials in Israel, and the developer believes it could help get vaccines to countries that are struggling to inoculate because of limited infrastructure. Oramed Pharmaceuticals has created a single-dose oral version of a prospective vaccine being developed by India-based Premas Biotech, and in March announced that it had successfully generated antibodies in pigs. It hopes that the Israeli-developed pill will be suitable as a simple initial vaccination, as it won’t need to be stored at low temperatures and eliminates the need to have professionals administering injections. READ MORE

ALGEMEINER A Simple Pill to Treat COVID-19? An Israeli Pharma Company May Have Potent Formula as Variant Fears Grow As concern over fast-spreading coronavirus variants continue among even highly-vaccinated populations, an Israel-based pharmaceutical company is hoping that its oral drug candidate will help get COVID-19 patients off oxygen support more quickly.